| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PRAE | 40.18 | 0.02 | +0.06% |
| PlanRock Equity Plus Alternatives ETF (PRAE) | |||
| PMMF | 100.32 | N/A | N/A |
| iShares Prime Money Market ETF (PMMF) | |||
| APRW | 37.94 | -0.01 | -0.04% |
| AllianzIM U.S. Equity Buffer20 Apr ETF (APRW) | |||
| SCHO | 23.89 | -0.08 | -0.33% |
| Schwab Short-Term US Treasury ETF (SCHO) | |||
| XITK | 182.27 | -1.86 | -1.01% |
| State Street SPDR FactSet Innovative Technology ETF (XITK) | |||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XITK | 182.27 | -1.86 | -1.01% |
| State Street SPDR FactSet Innovative Technology ETF (XITK) | |||
| SCHO | 23.89 | -0.08 | -0.33% |
| Schwab Short-Term US Treasury ETF (SCHO) | |||
| APRW | 37.94 | -0.01 | -0.04% |
| AllianzIM U.S. Equity Buffer20 Apr ETF (APRW) | |||
| PMMF | 100.32 | N/A | N/A |
| iShares Prime Money Market ETF (PMMF) | |||
| PRAE | 40.18 | 0.02 | +0.06% |
| PlanRock Equity Plus Alternatives ETF (PRAE) | |||
A.I.dvisor indicates that over the last year, GNOV has been closely correlated with FNOV. These tickers have moved in lockstep 98% of the time. This A.I.-generated data suggests there is a high statistical probability that if GNOV jumps, then FNOV could also see price increases.
| Ticker / NAME | Correlation To GNOV | 1D Price Change % | ||
|---|---|---|---|---|
| GNOV | 100% | -0.20% | ||
| FNOV - GNOV | 98% Closely correlated | -0.26% | ||
| FDEC - GNOV | 98% Closely correlated | -0.25% | ||
| FFEB - GNOV | 98% Closely correlated | -0.19% | ||
| PDEC - GNOV | 98% Closely correlated | -0.21% | ||
| PNOV - GNOV | 97% Closely correlated | -0.20% | ||
More | ||||
On November 04, 2026, the Stochastic Oscillator for GNOV moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 20 instances where the indicator left the oversold zone. In 16 of the 20 cases the stock moved higher in the following days. This puts the odds of a move higher at over 80%.
GNOV moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where GNOV advanced for three days, in 175 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
GNOV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 224 of 310 cases where GNOV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.
The 10-day RSI Indicator for GNOV moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 8 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 23%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GNOV as a result. In 20 of 43 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 47%.
The Moving Average Convergence Divergence Histogram (MACD) for GNOV turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 28 similar instances when the indicator turned negative. In 7 of the 28 cases the stock turned lower in the days that followed. This puts the odds of success at 25%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 34%.